You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Express Scripts
Dow
Harvard Business School
Johnson and Johnson

Last Updated: January 28, 2021

DrugPatentWatch Database Preview

Isradipine - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Drug Prices for isradipine

See drug prices for isradipine

Recent Clinical Trials for isradipine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Texas at AustinEarly Phase 1
The Parkinson Study GroupPhase 3
Michael J. Fox Foundation for Parkinson's ResearchPhase 3

See all isradipine clinical trials

Pharmacology for isradipine
Medical Subject Heading (MeSH) Categories for isradipine

US Patents and Regulatory Information for isradipine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Teva ISRADIPINE isradipine CAPSULE;ORAL 077317-001 Jan 5, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
Elite Labs Inc ISRADIPINE isradipine CAPSULE;ORAL 077169-001 Apr 24, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
Watson Labs Teva ISRADIPINE isradipine CAPSULE;ORAL 077317-002 Jan 5, 2006 AB RX No Yes   Start Trial   Start Trial   Start Trial
Smithkline Beecham DYNACIRC isradipine CAPSULE;ORAL 019546-002 Dec 20, 1990 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for isradipine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Llc DYNACIRC CR isradipine TABLET, EXTENDED RELEASE;ORAL 020336-002 Jun 1, 1994   Start Trial   Start Trial
Glaxosmithkline Llc DYNACIRC CR isradipine TABLET, EXTENDED RELEASE;ORAL 020336-002 Jun 1, 1994   Start Trial   Start Trial
Smithkline Beecham DYNACIRC isradipine CAPSULE;ORAL 019546-001 Dec 20, 1990   Start Trial   Start Trial
Glaxosmithkline Llc DYNACIRC CR isradipine TABLET, EXTENDED RELEASE;ORAL 020336-001 Jun 1, 1994   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Harvard Business School
Mallinckrodt
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.